Virtus ETF Advisers LLC Cti Biopharma Corp Transaction History

Virtus ETF Advisers LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$4.2 - $6.01 $3,906 - $5,589	930 Added 1.8%	52,472 $220,000
Q4 2022 Feb 14, 2023	BUY	$4.45 - $6.17 $36,365 - $50,421	8,172 Added 18.84%	51,542 $309,000
Q3 2022 Nov 14, 2022	BUY	$5.36 - $7.43 $3,403 - $4,718	635 Added 1.49%	43,370 $252,000
Q2 2022 Aug 12, 2022	BUY	$3.55 - $6.27 $151,709 - $267,948	42,735 New	42,735 $255,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.